Respiratory Training for Lymphoma Survivors
Trial Summary
What is the purpose of this trial?
High-resistance inspiratory muscle strength training (IMST) is a time-efficient (\~5 minutes/day) form of exercise that employs an affordable, handheld device which impedes inspiratory breathing to train the diaphragm and accessory respiratory muscles and has demonstrated improvements in both cardiovascular health (9 mmHg reduction in systolic blood pressure, 45% improvement in vascular endothelial function) and improve exercise tolerance (12% increase in treadmill exercise time) in generally healthy midlife/older adults. Therefore, this approach may circumvent preventative hurdles to exercise, and augment the effects of exercise for capable survivors.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you have recently changed your hypertensive medication, you may not be eligible to participate.
What data supports the effectiveness of the treatment Inspiratory Muscle Strength Training for lymphoma survivors?
Research shows that Inspiratory Muscle Training (IMT) can improve respiratory muscle strength and exercise capacity in patients with lung conditions, such as lung cancer and chronic obstructive pulmonary disease (COPD). This suggests that IMT might also help lymphoma survivors by strengthening their breathing muscles.12345
Is inspiratory muscle training (IMT) safe for humans?
How is the respiratory training treatment for lymphoma survivors different from other treatments?
This treatment is unique because it focuses on strengthening the respiratory muscles through inspiratory muscle training (IMT), which is not a standard approach for lymphoma survivors. IMT has been used in other conditions like lung cancer and chronic obstructive pulmonary disease (COPD) to improve breathing and exercise capacity, but its application in lymphoma survivors is novel.12346
Research Team
Ryan Marker, PT, PhD
Principal Investigator
University of Colorado, Denver
Eligibility Criteria
This trial is for lymphoma survivors aged 18-80 who've completed cancer treatment over a year ago, can exercise, and have a smartphone to use the training app. It's not for those with significant health issues like severe diabetes, heart disease, or unstable weight, nor for those doing lots of regular exercise already.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo high-resistance inspiratory muscle strength training (IMST) and personalized exercise prescription
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Inspiratory Muscle Strength Training
- Sham Inspiratory Muscle Strength Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Colorado, Denver
Lead Sponsor